{
    "paper_id": "77f4840c9bdd453ed8ae3c1ea4d79fc68a91e6ac",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Members of the coronavirus family responsible for severe acute respiratory syndrome (SARS-CoV) and Middle East respiratory syndrome (MERS-CoV) are known to be responsible for severe complications during pregnancy. 2, 3 12 pregnant women were infected with SARS-CoV during the 2002-03 pandemic. 2 Four (57%) of seven women in the first trimester had a miscarriage. In the second to third trimester, two (40%) of five women had fetal growth restriction, and four (80%) of five women had preterm birth (one spontaneous; three induced for maternal condition). Three (25%) women died during pregnancy.",
            "cite_spans": [
                {
                    "start": 214,
                    "end": 216,
                    "text": "2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 217,
                    "end": 218,
                    "text": "3",
                    "ref_id": "BIBREF2"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "In a review of 11 pregnant women infected with MERS-CoV, 3 ten (91%) presented with adverse outcomes, six (55%) neonates required admission to the intensive care unit, and three (27%) died. Two neonates were delivered prematurely for severe maternal respiratory failure.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Considering that the 2019-nCoV seems to have a similar pathogenic potential as SARS-CoV and MERS-CoV, 4 pregnant women are at increased risk of severe infections, there are no specific clinical signs of coronavirus infections preceding severe complications, 5 coronaviruses have the potential to cause severe maternal or perinatal adverse outcomes, or both, 2,3 and the current lack of data on the consequences of a 2019-nCoV infection during pregnancy, we recommend systematic screening of any suspected 2019-nCoV infection during pregnancy. If 2019-nCoV infection during pregnancy is confirmed, extended followup should be recommended for mothers and their fetuses.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Situation report-14",
            "authors": [],
            "year": 2020,
            "venue": "WHO. Novel coronavirus (2019-nCoV)",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "F"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Chow",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "N"
                    ],
                    "last": "Leung",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Am J Obstet Gynecol",
            "volume": "191",
            "issn": "",
            "pages": "292--97",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases & review of the literature",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Alfaraj",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Al-Tawfiq",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "A"
                    ],
                    "last": "Memish",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Microbiol Immunol Infect",
            "volume": "52",
            "issn": "",
            "pages": "501--504",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "China coronavirus: what do we know so far?",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Mahase",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "BMJ",
            "volume": "368",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "",
            "issn": "20",
            "pages": "30183--30188",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736"
                ]
            }
        }
    },
    "ref_entries": {},
    "back_matter": [
        {
            "text": "We declare no competing interests.Guillaume Favre, L\u00e9o Pomar, Didier Musso, *David Baud",
            "cite_spans": [],
            "ref_spans": [],
            "section": "acknowledgement"
        }
    ]
}